Skip to main content


EDM (Early Day Motion) 439: tabled on 29 October 2014

Tabled in the 2014-15 session.

This motion has been signed by 21 Members. It has not yet had any amendments submitted.

As this motion is using historical data, we may not have the record of the original ordering, in which case signatories are listed alphabetically.

Motion text

That this House pays tribute to the highly valuable and effective research and development (R&D) work into innovative global health goods carried out by public-private partnerships such as the European and Developing Countries Clinical Trials Partnership, the International AIDS Vaccine Alliance and the TB Alliance; highlights the important work these partnerships have done to accelerate the development of new or improved treatments, vaccines, microbicides, formulations and diagnostics against HIV/AIDS, tuberculosis and malaria with a focus on efficacy and implementation in affected regions such as sub-Saharan Africa; recognises that this work meets an urgent demand not currently met by market-based models of medical R&D and allows the integration and co-ordination of international research and the development of long-term medical research capacity in developing countries; and calls on the Government to maintain and employ its position as a leading funder of such partnerships to encourage increased contributions from other donor countries and private sector partners, particularly European Union member states.

The first 6 Members who have signed to support the motion are the sponsors. The primary sponsor is generally the person who tabled the motion and has responsibility for it. The date shown is when the Member signed the motion.

In addition to the sponsors, the following Members have signed to support the motion.

There are no withdrawn signatures for this motion.